146 related articles for article (PubMed ID: 33783485)
1. Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance.
Huang D; Wang X; Liu Y; Huang Z; Hu X; Hu W; Li Q; Chan H; Zou Y; Ho IHT; Wang Y; Cheng ASL; Kang W; To KF; Wang MHT; Wong SH; Yu J; Gin T; Zhang Q; Li Z; Shen J; Zhang L; Chan MTV; Liu X; Wu WKK
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33783485
[TBL] [Abstract][Full Text] [Related]
2. 3'untranslated regions of tumor suppressor genes evolved specific features to favor cancer resistance.
Huang D; Wang X; Huang Z; Liu Y; Liu X; Gin T; Wong SH; Yu J; Zhang L; Chan MTV; Chen H; Wu WKK
Oncogene; 2022 Jun; 41(23):3278-3288. PubMed ID: 35523946
[TBL] [Abstract][Full Text] [Related]
3. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
Samy MD; Yavorski JM; Mauro JA; Blanck G
Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
[TBL] [Abstract][Full Text] [Related]
4. Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction.
Zhang W; Flemington EK; Deng HW; Zhang K
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):198-207. PubMed ID: 30262601
[TBL] [Abstract][Full Text] [Related]
5. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
6. The multi-omic landscape of transcription factor inactivation in cancer.
Teschendorff AE; Zheng SC; Feber A; Yang Z; Beck S; Widschwendter M
Genome Med; 2016 Aug; 8(1):89. PubMed ID: 27562343
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.
Worm J; Guldberg P
J Oral Pathol Med; 2002 Sep; 31(8):443-9. PubMed ID: 12220350
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.
Shen L; Kondo Y; Guo Y; Zhang J; Zhang L; Ahmed S; Shu J; Chen X; Waterland RA; Issa JP
PLoS Genet; 2007 Oct; 3(10):2023-36. PubMed ID: 17967063
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
10. Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells.
Fukushige S; Kondo E; Horii A
Biochem Biophys Res Commun; 2008 Dec; 377(2):600-605. PubMed ID: 18929535
[TBL] [Abstract][Full Text] [Related]
11. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
12. Prediction of DNA methylation in the promoter of gene suppressor tumor.
Saif I; Kasmi Y; Allali K; Ennaji MM
Gene; 2018 Apr; 651():166-173. PubMed ID: 29408272
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
15. Bona Fide Tumor Suppressor Genes Hypermethylated in Melanoma: A Narrative Review.
Güvenç C; Neckebroeck F; Antoranz A; Garmyn M; van den Oord J; Bosisio FM
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639015
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor.
Deng G; Song GA; Pong E; Sleisenger M; Kim YS
Cancer Res; 2004 Apr; 64(8):2692-8. PubMed ID: 15087381
[TBL] [Abstract][Full Text] [Related]
17. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
18. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
